Zdrowie i gospodarka · 03/12/2004
NIH Seeks Exclusive License for Dendrimer-Based MRI Contrast Agents
The National Institutes of Health is issuing a notice under 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i) regarding its consideration of granting an exclusive worldwide license to practice a dendrimer-based MRI contrast agent invention.